Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Clinical Chemistry pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Clinical Chemistry segment comprises of reagents, test kits and electrodes which aid in determining the concentration or activity of biomolecules, such as protein, carbohydrate, lipid, enzyme, minerals or other small molecules.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Clinical Chemistry under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Clinical Chemistry and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Clinical Chemistry under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Clinical Chemistry Overview
Products under Development
Clinical Chemistry - Pipeline Products by Stage of Development
Table Clinical Chemistry - Pipeline Products by Stage of Development
Table Clinical Chemistry - Pipeline Products by Stage of Development
Clinical Chemistry - Pipeline Products by Segment
Table Clinical Chemistry - Pipeline Products by Segment
Table Clinical Chemistry - Pipeline Products by Segment
Clinical Chemistry - Pipeline Products by Territory
Table Clinical Chemistry - Pipeline Products by Territory
Table Clinical Chemistry - Pipeline Products by Territory
Clinical Chemistry - Pipeline Products by Regulatory Path
Table Clinical Chemistry - Pipeline Products by Regulatory Path
Table Clinical Chemistry - Pipeline Products by Regulatory Path
Clinical Chemistry - Pipeline Products by Estimated Approval Date
Table Clinical Chemistry - Pipeline Products by Estimated Approval Date
Table Clinical Chemistry - Pipeline Products by Estimated Approval Date
Table Immunobiogram - Renal Transplantation - Longitudinal Observational Study to Determine the Correlation Between Patient's Pharmacodynamic Response to Immunosuppressants Measured in Vitro with IMMUNOBIOGRAM and of Rejection in Graft Biopsies in Patients with Renal Transplantation
Table Ex Vivo 3D Drug Response (EV3D) Assay - 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells from Tumors: 3D-PREDICT REGISTRY
Kobe University Company Overview
Kobe University Pipeline Products & Ongoing Clinical Trials Overview
Table Kobe University Pipeline Products & Ongoing Clinical Trials Overview
Table UrSure POC Tenofovir Adherence Test - IPrEP: A Combination HIV Prevention Strategy for Young Women at Risk for HIV in Kisumu, Kenya IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya
Vanderbilt University Company Overview
Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
Table Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
Table Surface Enhanced Raman Scattering System - Product Status
Table Surface Enhanced Raman Scattering System - Product Description
Table Comprehensive Pharmacogenomics Panel Test - Product Status
Table Comprehensive Pharmacogenomics Panel Test - Product Description
Withings SA Company Overview
Withings SA Pipeline Products & Ongoing Clinical Trials Overview
Table Withings SA Pipeline Products & Ongoing Clinical Trials Overview
Table U-Scan - Product Status
Table U-Scan - Product Description
Clinical Chemistry- Recent Developments
Dec 12, 2023: Nusano to Host December 19 Virtual KOL Event on Emerging Trends in Radiotherapeutics
Dec 12, 2023: Genentech Announces Appointment of Ashley Magargee as Chief Executive Officer
Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations
Dec 04, 2023: Stefan Blomsterberg Appointed as New CEO of CELLINK Bioprinting AB
Dec 04, 2023: UCF Welcomes Alum and Distinguished Military Leader as Associate VP of Federal Affairs
Dec 04, 2023: Inventia Life Science Announces Third Dimension Grant for 3D Cell Culture Research
Nov 30, 2023: Wilmot L. Matthews Announces Resignation as Director of SQI Diagnostics Debt Forgiveness, Voting Trust Agreement and Related Transactions
Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes
Nov 27, 2023: Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker s MALDI Biotyper
Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East
Nov 23, 2023: Cambridge Nutritional Sciences Reports Earnings Results for the Half Year Ended September 30, 2023
Nov 22, 2023: Biohit Renews Its Strategy to Accelerate Profitable Growth Changes in the Management Team
Nov 21, 2023: BD Names Dr. Ronald Silverman as Chief Medical Officer
Nov 21, 2023: UK Medical Devices Regulations: TUV Rheinland is now a UK Approved Body according to UK MDR
Nov 17, 2023: Pangenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests
Nov 14, 2023: MilliporeSigma Launches ChemisTwin, First Ever Digital Reference Material Platform for Analytical Testing
Nov 14, 2023: International Isotopes Announces Fiscal Results for the Third Quarter and First Nine Months of 2023
Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
Nov 08, 2023: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
Nov 07, 2023: Abbott Laboratories Receives Additional 510(K) Clearance for i-STAT CG8+ cartridge with the i-STAT 1 System
Nov 07, 2023: Abbott Laboratories Receive Additional 510(K) Clearance for i-STAT CG8+ cartridge with the i-STAT 1 System
Nov 07, 2023: Abbott Laboratories Received Additional 510(K) Clearance for i-STAT CG8+ cartridge with the i-STAT 1 System
Nov 07, 2023: Calmark Ships Instruments to India for a Method Comparison Study
Nov 07, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
Nov 07, 2023: Asahi Kasei Announces Consolidated Results for 1st and 2nd Quarter Fiscal 2023: April 1, 2023 - September 30, 2023
Nov 03, 2023: Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
Nov 02, 2023: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
Nov 01, 2023: Kyowa Kirin Announces Results Presentation Fiscal 2023 Third Quarter
Nov 01, 2023: IDEXX Laboratories Announces Third Quarter Results
Oct 31, 2023: Samsung Electronics Reports Q3 2023 Results
Oct 30, 2023: Revvity Announces Financial Results for the Third Quarter of 2023
Oct 27, 2023: Tokuyama Corp Announces Consolidated Financial Statements for the Second Quarter Fiscal 2023
Oct 27, 2023: Clario's Precision Motion Opal Technology Powers University of Oxford Breakthrough in Parkinson's Disease
Oct 26, 2023: AddLife Interim Report 1 January - 30 September 2023
Oct 26, 2023: AddLife Announces Interim Report 1 January - 30 September 2023
Oct 26, 2023: Summit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023
Oct 24, 2023: Waters Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division
Oct 19, 2023: H. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Development
Oct 19, 2023: bioMérieux Makes Strategic Investment in Oxford Nanopore
Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
Oct 17, 2023: Yosemite's Beverly Lu, Ph.D. joins Ten63's Board of Directors
Oct 17, 2023: BD Names Greg Rodetis as Senior Vice President of Investor Relations
Oct 16, 2023: ProciseDx Receives DeNovo Clearance for Procise ADL
Oct 16, 2023: ProciseDx Receives DeNovo Clearance for Procise IFX
Oct 16, 2023: Genabio Diagnostics Obtains CLIA Approval for GenaCheck Rapid Self-Test Kit For FOB
Oct 16, 2023: Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer
Oct 16, 2023: HealthBeacon: Directorate Change
Oct 11, 2023: Theradiag Reports 20% Revenue Growth in Q3 2023
Oct 11, 2023: Eurobio Scientific : Results for the First Half of 2023
Oct 10, 2023: AZOVA Launches Innovative UTI Telehealth Bundle
Oct 09, 2023: Revvity To Hold Earnings Call on Monday, October 30, 2023
Oct 05, 2023: HealthBeacon Announces Interim Results 2023
Oct 05, 2023: Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023
Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
Oct 04, 2023: URI Metcalf Institute Appoints Veteran Journalist Fara Warner as New Executive Director
Oct 03, 2023: Procisedx Announces the First FDA-Cleared Therapeutic Drug Monitoring Tests for Biologic Drugs, Humira, Remicade, and Their Biosimilars
Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer
Oct 03, 2023: Merck India Expands Infrastructure to Capitalise on Growing Pharmaceutical Industry
Sep 29, 2023: Abbott Point of Care Obtains 510(k) Clearance for i-STAT G3+ Cartridge With The i- STAT 1 System
Sep 28, 2023: Genedrive to Benefit From c£1.2m Grant Awarded for the Validation of the Genedrive CYP2C19 ID Kit
Sep 28, 2023: Span Divergent Notice of43rd Annual General Meeting
Sep 27, 2023: Abbott Point of Care Receives 510(k) Clearance for i-STAT G Cartridge With The i- STAT 1 System
Sep 26, 2023: Clario Teams up With CellCarta to Transform Clinical Trial Sample Management for Histopathology Studies
Sep 25, 2023: Randox Laboratories Receives 510(k) Clearance for ISE Electrode
Sep 25, 2023: Ginkgo Bioworks and the Government of the Republic of Madagascar Announce Plans to Develop New Biosecurity Capabilities
Sep 21, 2023: Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director And Enters Cooperation Agreement with Shareholder MKT Capital
Sep 20, 2023: Bristol Myers Squibb appoints new Senior Vice President and Head of Major Markets
Sep 20, 2023: Scientists See the Light with Diabetes and Hypertension Breakthrough
Sep 18, 2023: Caltech Announces New Vice President and Chief Operating Officer
Sep 11, 2023: Aspira Women's Health Announces Dr. Jody Berry as New Chief Scientific Officer
Sep 11, 2023: Genedrive Appoints New Chief Executive and Chief Scientific Officer
Sep 11, 2023: Dirui Industrial Appoints Lin Maoliang as Non-Independent Directors
Sep 07, 2023: UCF Names Saiful Khondaker as Interim Assistant Vice President for Research Advancement
Sep 07, 2023: The FNIH Announces Study Results Published in Nature Medicine Showing That Liver Disease Can Be Diagnosed Using Noninvasive Blood Tests
Sep 06, 2023: Calmark's Neo Product for Bilirubin Is Registered in Turkey
Sep 06, 2023: Genedrive : UKCA Marking Achieved for New Genedrive CYP2C19 Test
Sep 06, 2023: ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Sep 05, 2023: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer
Jul 04, 2023: Siemens Healthcare Diagnostics Receives 510(k) Clearance for Atellica CH Diazo Direct Bilirubin (D_DBil) Assay
Jul 01, 2023: Siemens Healthcare names Hariharan Subramanian as the Managing Director
Jun 30, 2023: MedMira Reports Third Quarter Results FY2023
Jun 29, 2023: Kiyatec and Xenostart Formally Announce a Collaborative Agreement to Help Reduce Drug Development Costs by Providing Correlative Ex Vivo Efficacy Data Using Kiyatec's 3D Spheroid Screening Platform, Kiya-Predict
Jun 28, 2023: Kyowa Kirin Announces Annual Report 2022
Jun 27, 2023: bioMErieux's Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations
Jun 26, 2023: Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
Jun 26, 2023: Calmark Receives Follow-up Order From Italy
Jun 20, 2023: Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis
Jun 19, 2023: Avvy Health Partners With Otsuka Canada Pharmaceutical To Provide Home Blood Test Service
Jun 16, 2023: Multi-Partner Grant Awarded for the Validation of Genedrive CYP2C19 ID Kit in Time Critical NHS Settings
Jun 14, 2023: Biohit Announces Decisions of the Annual General Meeting
Jun 14, 2023: Biohit Decisions of the Annual General Meeting
Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
Jun 07, 2023: Abbott Diagnostics Receives Additional 510(k) Clearance for Alinity c Glucose Reagent Kit
Jun 07, 2023: Carethetic Group receives CLIA approval for Carethetic Multi Drug Test Panel
Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR 0.50 per Share
Jun 05, 2023: American Screening receives CLIA approval for Discover Plus Multi-Panel Drug Test Cup Rx
Jun 05, 2023: American Screening receives CLIA approval for Precision DX Multi-Panel Drug Test Cup Rx
Jun 05, 2023: American Screening receives CLIA approval for Precision Plus Multi-Panel Drug Test Cup Rx
Jun 05, 2023: American Screening receives CLIA approval for G-Card Drug Test Dip Card Rx
Jun 05, 2023: American Screening receives CLIA approval for G-Cup Multi-Panel Drug Test Cup Rx
Jun 05, 2023: American Screening receives CLIA approval for Onescreen Multi-Panel Drug Test Cup Rx
Jun 05, 2023: Biocartis Announces Resignation CFO
Jun 04, 2023: Abbott Diagnostics receives additional 510(k) clearance for Alinity c ICT Sample Diluent
Jun 02, 2023: Avacta Group Posting of Annual Report and Notice of AGM
Jun 02, 2023: Illumina's Board of Directors elects two experienced Independent Directors to Board
Jun 02, 2023: Agilent Intelligent Mass Spectrometry Solutions to Inspire at ASMS 2023
May 31, 2023: NetScientific reports results for year ended December 31, 2022
May 30, 2023: SQI Diagnostics reports second quarter 2023 results
May 25, 2023: DiagnaMed Launches palgpt.AI, a Generative AI Brain Health Solution
May 23, 2023: Tigermed Consulting Announces Appointment of Chairman of The Board and The Supervisory Committee
May 23, 2023: Hangzhou Tigermed Consulting Co. announces poll voting results of the 2022 annual general meeting
May 22, 2023: Opentrons Flex lab robot launches to accelerate bioautomation across thousands of life science experiments
May 22, 2023: Span Divergent Announces Results for the Quarter and Year Ended on March 31, 2023
May 19, 2023: genedrive : NICE recommends CYP2C19 genotyping for clopidogrel treatment
May 19, 2023: General Industrial Smiths Group announces Q3 trading statement
May 16, 2023: Hangzhou Tigermed Consulting Co.: Change of venue of annual general meeting and the h share class meeting to be held on May 23, 2023
May 16, 2023: Genflow Biosciences Notice of Annual General Meeting
May 15, 2023: T2 Biosystems postpones reporting of first quarter 2023 financial results
May 12, 2023: Acurx Pharmaceuticals reports first quarter 2023 results and provides business update
May 12, 2023: Biocartis Group announces results of the annual shareholders meeting held on 12 May 2023
May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023
May 12, 2023: HU Group announces consolidated financial results for the fiscal year ended March 31, 2023
May 12, 2023: Horiba announces summary of consolidated financial statements for the three months ended March 31, 2023
May 11, 2023: Healthy.io and Boehringer partner on at-home testing for CKD
May 11, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
May 11, 2023: Nusano announces in-house stable isotope program led by renowned physicist Sarko Cherekdjian
May 10, 2023: ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
May 10, 2023: VolitionRx announces first quarter 2023 financial results and business update
May 10, 2023: Kyowa Kirin Announces Appendix to the Consolidated Financial Summary Fiscal 2023 First Quarter
May 10, 2023: Kyowa Kirin announces consolidated financial summary fiscal 2023 Q1
May 09, 2023: Grifols delivers strong first quarter financials with 23% revenue growth and an adjusted EBITDA margin above guidance of 21%
May 09, 2023: LumiraDx to announce first quarter financial results and host quarterly conference call on May 16
May 09, 2023: Natera reports first quarter 2023 financial results
May 05, 2023: Ginkgo Bioworks announces appointment of Steven P. Coen as chief accounting officer
May 05, 2023: VolitionRx schedules first quarter 2023 earnings conference call and business update
May 05, 2023: Acurx Pharmaceuticals to discuss first quarter 2023 financial results and provide business update
May 04, 2023: AddLife Notice of Annual General Meeting
May 04, 2023: Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radiopharmaceuticals
May 03, 2023: Health Recovery Solutions Announces Alan Bugos as New Chief Technology Officer
May 03, 2023: Adaptive Biotechnologies reports First Quarter 2023 financial results
May 02, 2023: Calmark Receives Order From Mediq in Sweden
May 01, 2023: Genomic urine test detects bladder cancer from DNA Up to 12 years before clinical signs and symptoms appear
Apr 28, 2023: Arkray receives CLIA approval for AUTION MAX AX-4060 Urinalysis System
Apr 28, 2023: Siemens to announce second quarter results FY 2023
Apr 17, 2023: Nusano announces Q1 2025 opening date for medical radioisotope production facility in Utah
Apr 13, 2023: Smiths Group announces director declaration
Apr 11, 2023: Kiyatec to present two posters highlighting the company's work in ex vivo immunooncology at the 2023 AACR Annual Meeting April 14-19, in Orlando, FL
Apr 11, 2023: Biocartis appoints Roger Moody as new CEO
Apr 09, 2023: Syncell showcases pioneering microscopy-guided subcellular protein scooping technology at the AACR Annual Meeting 2023
Apr 06, 2023: International Isotopes Announces 2022 Year End Financial Results
Apr 04, 2023: MedMira Reports Second Quarter Results FY2023
Apr 03, 2023: Siemens Healthcare Diagnostics receives additional 510(k) clearance for Revised CReactive Protein (RCRP) Flex Reagent Cartridge
Apr 03, 2023: Sysmex Europe launches the UF-1500 fully automated urine particle analyser, a new product for the urine particle analysis testing field
Apr 03, 2023: Avacta Group Announces Notice of Financial Results for 31 December 2022
Apr 03, 2023: Shanghai Kehua's Board Elects Li Ming As Company President
Mar 31, 2023: AddLife Announces Annual Report for 2022
Mar 31, 2023: Fujirebio further extends its fully automated blood-based biomarker portfolio with the fully automated Lumipulse G ApoE4 and Lumipulse G Pan-ApoE assays for research use only
Mar 31, 2023: HealthBeacon Announces 2022 Preliminary Results
Mar 30, 2023: ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
Mar 29, 2023: Notice to attend the Annual General Meeting of AddLife AB
Mar 28, 2023: ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update
Mar 28, 2023: Health Recovery Solutions Announces New Client Advisory Board
Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022
Mar 23, 2023: Celcuity Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Mar 22, 2023: Biohit Announces Annual Report 2022
Mar 22, 2023: DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product
Mar 22, 2023: EditForce raised a total of 1.8 billion yen through a third-party allotment of new shares
Mar 21, 2023: Four innovative tests for diagnosing UTIs could help in the fight against antimicrobial resistance
Mar 17, 2023: When time matters, rapid point of care testing can support treatment decisions
Mar 16, 2023: Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
Mar 16, 2023: Incannex to Commercialise its Psychedelic Clinics Business in Collaborative Partnership with Leading Psychedelic Experts
Mar 16, 2023: Thermogenesis Announces $3 Million Private Placement Priced at-the-market Under Nasdaq Rules
Mar 15, 2023: TruDiagnostic and NADMED launch new blood diagnostic in US
Mar 15, 2023: Clario Announces Global Clinical Research Expert, Rod MacKenzie CMG, PH.D., New Chairman of the Board of Directors
Mar 15, 2023: VolitionRx Announces Full Fiscal Year 2022 Financial Results and Business Update
Mar 14, 2023: LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
Mar 10, 2023: VolitionRx Schedules Full Year 2022 Earnings Conference Call and Business Update
Mar 09, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022
Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 08, 2023: The National Kidney Foundation and Healthy.io partner to increase access to testing for detection of kidney disease
Mar 08, 2023: Otsuka Pharmaceutical Announces Appointments of Board Members and Statutory Auditors
Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022
Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
Mar 08, 2023: Asahi Kasei Corp. Announces Change in Representative Directors
Mar 06, 2023: VolitionRx to Webcast Live at VirtualInvestorConferences.com March 9th
Mar 03, 2023: Grifols Announces Full Year 2022 Earnings
Mar 02, 2023: Prometheus launches new indication for PredictrPK IFX, a precision-guided dosing test for IBD
Feb 28, 2023: Reset Kidney Health and Healthy.io to offer smartphone-based kidney testing
Feb 27, 2023: Applied BioCode Announces 2022 Q4 and Full year Revenue
Feb 27, 2023: Merlin Announces Two Executive Hires to Advance the Merlin Pilot's Capabilities and Commercialization
Feb 27, 2023: BioMarin Announces Record Fourth Quarter and Full Year 2022 Results
Feb 27, 2023: Tokuyama Corp. Notice concerning Change of Representative Director
Feb 24, 2023: Diagnostix elects Ger van Jeveren to its board of directors ahead of IPO
Feb 23, 2023: Biocartis announces 2022 results and 2023 outlook
Feb 23, 2023: Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors
Feb 23, 2023: binx health to Present at the Upcoming BioCapital Europe 2023 Conference
Feb 22, 2023: Thomas Glanzmann new Grifols Executive Chairman, after Steven F. Mayer resignation
Feb 22, 2023: Monod Bio announces publication in nature highlighting de novo protein technology platform for the creation of novel luciferases
Feb 21, 2023: IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
Feb 21, 2023: Halberd demonstrates simultaneous eradication of multiple strains of CDC provided antibiotic resistant bacteria
Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
Feb 16, 2023: Samsung Electronics Announces 2022 Consolidated Financial Statements
Feb 15, 2023: Biohit Announces Group Financial Statements Release
Feb 15, 2023: Mahana Therapeutics Appoints Justin Zamirowski, Jr. as Chief Commercial Officer
Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations
Feb 14, 2023: Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 14, 2023: Horiba Announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2022
Feb 13, 2023: DiagnaMed Announces Appointment of New Director
Feb 13, 2023: Assayquant Technologies expands panel for Kinome profiling services
Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Fullyear Forecasts for Fiscal 2023
Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
Feb 09, 2023: SenzaGen Invitation to the presentation of year-end report 2022 on Feb 16 at 14.00 CET
Feb 09, 2023: Takara Bio Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (Dividend Increase)
Feb 09, 2023: Oxford scientists develop test that can identify respiratory viruses within five minutes
Feb 08, 2023: Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO
Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023
Feb 08, 2023: NTU appoints NUS provost Ho Teck Hua as university's new president
Feb 08, 2023: Asahi Kasei Announces Consolidated Results for 1st to 3rd Quarter Fiscal 2022
Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
Feb 08, 2023: H.U. Group Holdings Announces Consolidated Financial Results for the Nine Months Ended December 31, 2022
Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023
Feb 07, 2023: Shanghai Genext Medical Technology receives CLIA clearance for AU480 Clinical Chemistry Analyzer - Tacrolimus Assay Kit
Feb 07, 2023: Kyowa Kirin Announces Consolidated Financial Summary for Fiscal Year Ended December 31, 2022
Feb 07, 2023: Cytek Biosciences partners with Bio-Rad to expand reagent portfolios
Feb 07, 2023: Unchained Labs goes viral again with new adenovirus quant application on stunner
Feb 07, 2023: QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
Feb 07, 2023: BioMark receives funding, support, research and development project for cancer treatment monitoring
Feb 06, 2023: Surmodics Lays off 58 employees
Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Feb 03, 2023: Shanghai Genext Medical Technology receives 510(k) clearance for Tacrolimus Assay Kit
Feb 03, 2023: Thermo Scientific Nicolet RaptIR FTIR microscope quickly collects and analyzes highspatial resolution data with agility and acuity
Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022
Feb 01, 2023: Novartis Announces Annual Report 2022
Feb 01, 2023: Cairn Homes Announces Ms. Orla O'Gorman step down as Non-Executive Director of HealthBeacon
Feb 01, 2023: Techno Medica Announces Non-consolidated Financial Results for the Nine Months Ended December 31,2022
Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders
Jan 31, 2023: Tokuyama Announces Summary of Consolidated Financial Statements for the Third Quarter Fiscal 2022
Jan 26, 2023: Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Jan 26, 2023: ACS Laboratory receives a total of 82 emerald badges for exemplary hemp and cannabis test results, more than any laboratory in the USA
Jan 26, 2023: Nautilus Biotechnology expands to San Diego
Jan 23, 2023: Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results
Jan 20, 2023: Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023
Jan 20, 2023: Joint statement by Executive Steering Group on shortages and safety of medicinal products (MSSG) on shortages of antibiotic medicines